Antimalarial Drugs
Chemistry, Development & Future Challenges


A Celebration of  the EU FP6 funded AntiMal project in association with the Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry


The meeting is relevant to basic and translational scientists with an interest in medicinal chemistry, chemotherapy, pharmacology and infectious disease biology. The speakers and topics have been selected to provide a broad “state of the art” perspective that should be of particular value to younger scientists.


Venue: Royal College of Physicians, London



RCP Logo


15th and 16th March 2011


Phil Rosenthal

University of California


Tim Wells

Medicines for Malaria Venture


Yongyuth Yuthavong

NSTDA Bangkok


Vicky Avery

Griffith University, Australia


Stephen Ward

Liverpool School of Tropical Medicine


Sanjeev Krishna

St Georges University Hospital


Elizabeth Winzeler

Novartis Research Foundation


David Fox



Kelly Chibale

University of Cape Town


Henri Vial

University of Montpellier - CNRS


Dennis Kyle

University of South Florida


Christian Doerig

EPFL-INSERM, Switzerland


Arnab Chatterjee

Genomics Institute of the Novartis Research Institute


Paul O’Neill

University of Liverpool